FCGR3A and neoplasm: Specifically, FcγRIIIa-V158 has a higher affinity to human IgG1 and IgG3 than does FcγRIIIa-158F, this stronger binding affinity results in more potent in vitro ADCC and tumor cell death (Koene et al., 1997).